Technical Analysis for OMIC - Singular Genomics Systems, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 0.55 | 9.48% | 0.05 |
OMIC closed up 9.48 percent on Monday, March 18, 2024, on 65 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Crossed Above 200 DMA | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Earnings Movers | Other | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | 9.48% | |
Narrow Range Bar | Range Contraction | 9.48% | |
Stochastic Reached Oversold | Weakness | 9.48% | |
Inside Day | Range Contraction | 9.48% | |
Oversold Stochastic | Weakness | 9.48% |
Alert | Time |
---|---|
Rose Above 20 DMA | about 16 hours ago |
Rose Above 200 DMA | about 16 hours ago |
Up 10% | about 16 hours ago |
Up 1 ATR | about 16 hours ago |
60 Minute Opening Range Breakout | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/18/2024
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Life Sciences Biology Molecular Biology Genomics Proteomics Life Science Technology
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Life Sciences Biology Molecular Biology Genomics Proteomics Life Science Technology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.58 |
52 Week Low | 0.3101 |
Average Volume | 111,492 |
200-Day Moving Average | 0.54 |
50-Day Moving Average | 0.51 |
20-Day Moving Average | 0.55 |
10-Day Moving Average | 0.53 |
Average True Range | 0.05 |
RSI (14) | 52.15 |
ADX | 15.95 |
+DI | 24.28 |
-DI | 15.22 |
Chandelier Exit (Long, 3 ATRs) | 0.50 |
Chandelier Exit (Short, 3 ATRs) | 0.64 |
Upper Bollinger Bands | 0.61 |
Lower Bollinger Band | 0.48 |
Percent B (%b) | 0.49 |
BandWidth | 24.23 |
MACD Line | 0.00 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0069 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.63 | ||||
Resistance 3 (R3) | 0.63 | 0.59 | 0.62 | ||
Resistance 2 (R2) | 0.59 | 0.57 | 0.59 | 0.61 | |
Resistance 1 (R1) | 0.57 | 0.56 | 0.58 | 0.58 | 0.61 |
Pivot Point | 0.53 | 0.53 | 0.54 | 0.54 | 0.53 |
Support 1 (S1) | 0.51 | 0.51 | 0.52 | 0.52 | 0.49 |
Support 2 (S2) | 0.48 | 0.50 | 0.48 | 0.48 | |
Support 3 (S3) | 0.46 | 0.48 | 0.48 | ||
Support 4 (S4) | 0.46 |